Drug Information

Drug General Information
Drug ID
D07MAF
Former ID
DNC009794
Drug Name
3-(dimethylamino)-1-(4-heptylphenyl)propan-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530166]
Structure
Download
2D MOL

3D MOL
Formula
C18H29NO
Canonical SMILES
CCCCCCCC1=CC=C(C=C1)C(=O)CCN(C)C
InChI
1S/C18H29NO/c1-4-5-6-7-8-9-16-10-12-17(13-11-16)18(20)14-15-19(2)3/h10-13H,4-9,14-15H2,1-3H3
InChIKey
ANCSLKGKDIAGLN-UHFFFAOYSA-N
PubChem Compound ID
21653696
Target and Pathway
Target(s) Thyroid hormone receptor beta-1 Target Info Inhibitor [530166]
Potassium voltage-gated channel subfamily H member 2 Target Info Inhibitor [530166]
KEGG Pathway Neuroactive ligand-receptor interaction
Thyroid hormone signaling pathway
Pathway Interaction Database RXR and RAR heterodimerization with other nuclear receptor
PathWhiz Pathway Muscle/Heart Contraction
Reactome Nuclear Receptor transcription pathwayR-HSA-1296072:Voltage gated Potassium channels
WikiPathways SIDS Susceptibility Pathways
Hematopoietic Stem Cell Differentiation
Nuclear ReceptorsWP706:SIDS Susceptibility Pathways
Potassium Channels
References
Ref 530166J Med Chem. 2009 Jul 9;52(13):3892-901.Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.
Ref 530166J Med Chem. 2009 Jul 9;52(13):3892-901.Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.